NCT07100730 2026-03-12IPAX BrIGHTTelix Pharmaceuticals (Innovations) Pty LimitedPhase 3 Recruiting50 enrolled
NCT00068952 2008-04-01Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma MultiformePfizerPhase 3 Completed118 enrolled